Review article: Role of PPARs in radiation-induced brain injury

PPAR Research

Volumn , Issue , 2010, Pages

  Ramanan, Sriram ^a   Zhao, Weiling ^a   Riddle, David R ^a   Robbins, Mike E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; [4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; FENOFIBRATE; GEMFIBROZIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE;

ACQUIRED BRAIN INJURY; ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN RADIATION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEGENERATIVE DISEASE; ENCEPHALITIS; HUMAN; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RADIATION INDUCED BRAIN INJURY; RADIATION INJURY; REVIEW; WHITE MATTER;

EID: 84868309553     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/234975     Document Type: Review

References (139)

1. T. Lemberger, B. Desvergne, and W. Wahli, "Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology, " Annual Review of Cell and Developmental Biology, vol. 12, no. 11, pp. 335-363, 1996. (Pubitemid 26422717)
2. C. Blanquart, O. Barbier, J. C. Fruchart, B. Staels, and C. Glineur, "Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation, " Journal of Steroid Biochemistry andMolecular Biology, vol. 85, no. 2-5, pp. 267-273, 2003. (Pubitemid 37011102)
3. Nuclear Receptors Nomenclature Committee, "A unified nomenclature system for the nuclear receptor superfamily, " Cell, vol. 97, no. 2, pp. 161-163, 1999.
4. O. Braissant, F. Foufelle, C. Scotto, M. Dauça, and W. Wahli, "Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat, " Endocrinology, vol. 137, no. 1, pp. 354-366, 1996. (Pubitemid 26005011)
5. T. E. Cullingford, K. Bhakoo, S. Peuchen, C. T. Dolphin, R. Patel, and J. B. Clark, "Distribution of mRNAs encoding the peroxisome proliferator-activated receptor α, β, and γ and the retinoid X receptor α, β, and γ in rat central nervous system, " Journal of Neurochemistry, vol. 70, no. 4, pp. 1366-1375, 1998. (Pubitemid 28136948)
6. S. A. Kliewer, K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans, "Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, " Nature, vol. 358, no. 6389, pp. 771-774, 1992.
7. L. Michalik, J. Auwerx, J. P. Berger, et al., "International union of pharmacology. LXI. Peroxisome proliferator-activated receptors, " Pharmacological Reviews, vol. 58, no. 4, pp. 726-741, 2006. (Pubitemid 44833742)
8. T. M. Willson, P. J. Brown, D. D. Sternbach, and B. R. Henke, "The PPARs: from orphan receptors to drug discovery, " Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 527-550, 2000. (Pubitemid 30127149)
9. P. Lefebvre, G. Chinetti, J.-C. Fruchart, and B. Staels, "Sorting out the roles of PPARα in energy metabolism and vascular homeostasis, " Journal of Clinical Investigation, vol. 116, no. 3, pp. 571-580, 2006. (Pubitemid 43326861)
10. J. Auwerx, K. Schoonjans, J. C. Fruchart, and B. Staels, "Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects, " Journal of Atherosclerosis and Thrombosis, vol. 3, no. 2, pp. 81-89, 1996.
11. L. Berthou, N. Duverger, F. Emmanuel, et al., "Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice, " Journal of Clinical Investigation, vol. 97, no. 11, pp. 2408-2416, 1996. (Pubitemid 26187327)
12. B. M. Forman, J. Chen, and R. M. Evans, "Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 9, pp. 4312-4317, 1997. (Pubitemid 27194238)
13. M.-B. Debril, J.-P. Renaud, L. Fajas, and J. Auwerx, "The pleiotropic functions of peroxisome proliferator-activated receptor γ, " Journal of Molecular Medicine, vol. 79, no. 1, pp. 30-47, 2001. (Pubitemid 32250021)
14. E. D. Rosen and B. M. Spiegelman, "PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth, " Journal of Biological Chemistry, vol. 276, no. 41, pp. 37731-37734, 2001.
15. Y. Zhu, C. Qi, J. R. Korenberg, et al., "Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms, " Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 17, pp. 7921-7925, 1995.
16. P. R. S. Baker, F. J. Schopfer, V. B. O'Donnell, and B. A. Freeman, "Convergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acids, " Free Radical Biology and Medicine, vol. 46, no. 8, pp. 989-1003, 2009.
17. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer, "An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ), " Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953-12956, 1995.
18. J. J. Nolan, B. Ludvik, P. Beerdsen, M. Joyce, and J. Olefsky, "Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone, " The New England Journal of Medicine, vol. 331, no. 18, pp. 1188-1193, 1994. (Pubitemid 24331336)
19. J. M. Lehmann, J. M. Lenhard, B. B. Oliver, G. M. Ringold, and S. A. Kliewer, "Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs, " Journal of Biological Chemistry, vol. 272, no. 6, pp. 3406-3410, 1997.
20. R. P. Brun, P. Tontonoz, B. M. Forman, et al., "Differential activation of adipogenesis bymultiple PPAR isoforms, " Genes & Development, vol. 10, no. 8, pp. 974-984, 1996. (Pubitemid 26138708)
21. L. Michalik, B. Desvergne, and W. Wahli, "Peroxisome proliferator-activated receptors β/δ: emerging roles for a previously neglected third family member, " Current Opinion in Lipidology, vol. 14, no. 2, pp. 129-135, 2003. (Pubitemid 36521182)
22. D. J. Kim, I. A. Murray, A. M. Burns, F. J. Gonzalez, G. H. Perdew, and J. M. Peters, "Peroxisome proliferator-activated receptor-β/δ inhibits epidermal cell proliferation by downregulation of kinase activity, " Journal of Biological Chemistry, vol. 280, no. 10, pp. 9519-9527, 2005. (Pubitemid 40409647)
23. I. Saluja, J. G. Granneman, and R. P. Skoff, "PPAR δ agonists stimulate oligodendrocyte differentiation in tissue culture, " Glia, vol. 33, no. 3, pp. 191-204, 2001. (Pubitemid 32219128)
24. J. M. Peters, S. S. T. Lee, W. Li, et al., "Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ), " Molecular and Cellular Biology, vol. 20, no. 14, pp. 5119-5128, 2000. (Pubitemid 30431565)
25. J. W. Woods, M. Tanen, D. J. Figueroa, et al., "Localization of PPARδ in murine central nervous system: expression in oligodendrocytes and neurons, " Brain Research, vol. 975, no. 1-2, pp. 10-21, 2003. (Pubitemid 36588548)
26. A. Benani, P. Kremarik-Bouillaud, A. Bianchi, P. Netter, A. Minn, and M. Dauça, "Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord, " Journal of Chemical Neuroanatomy, vol. 25, no. 1, pp. 29-38, 2003. (Pubitemid 36164853)
27. J. J. Bright, S. Kanakasabai, W. Chearwae, and S. Chakraborty, "PPAR regulation of inflammatory signaling in CNS diseases, " PPAR Research, vol. 2008, Article ID 658520, 12 pages, 2008.
28. M. T. Heneka and G. E. Landreth, "PPARs in the brain, " Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 1031-1045, 2007. (Pubitemid 47208548)
29. S. Moreno, S. Farioli-Vecchioli, and M. P. Ceru, "Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS, " Neuroscience, vol. 123, no. 1, pp. 131-145, 2004. (Pubitemid 37518482)
30. A. Cimini, L. Cristiano, E. Benedetti, B. D'Angelo, and M. P. Ceru, "PPARs expression in adult mouse neural stem cells: modulation of PPARs during astroglial differentiaton of NSC, " PPAR Research, vol. 2007, Article ID 48242, 10 pages, 2007.
31. K. Wada, A. Nakajima, K. Katayama, et al., "Peroxisome proliferator-activated receptor γ-mediated regulation of neural stem cell proliferation and differentiation, " Journal of Biological Chemistry, vol. 281, no. 18, pp. 12673-12681, 2006. (Pubitemid 43855357)
32. R. A. Daynes and D. C. Jones, "Emerging roles of PPARs in inflammation and immunity, " Nature Reviews Immunology, vol. 2, no. 10, pp. 748-759, 2002. (Pubitemid 37328715)
33. R. Bordet, T. Ouk, O. Petrault, et al., "PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases, " Biochemical Society Transactions, vol. 34, no. 6, pp. 1341-1346, 2006. (Pubitemid 46769051)
34. C.K. Combs, D.E. Johnson, J. C. Karlo, S. B. Cannady, andG. E. Landreth, "Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists, " Journal of Neuroscience, vol. 20, no. 2, pp. 558-567, 2000. (Pubitemid 30225558)
35. M. T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, et al., "Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice, " Brain, vol. 128, no. 6, pp. 1442-1453, 2005. (Pubitemid 40826196)
36. M. Hirohata, K. Ono, H. Naiki, and M. Yamada, "Nonsteroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro, " Neuropharmacology, vol. 49, no. 7, pp. 1088-1099, 2005. (Pubitemid 41503307)
37. G. S. Watson, B. A. Cholerton, M. A. Reger, et al., "Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study, " The American Journal of Geriatric Psychiatry, vol. 13, no. 11, pp. 950-958, 2005. (Pubitemid 46638661)
38. T. Dehmer, M. T. Heneka, M. Sastre, J. Dichgans, and J. B. Schulz, "Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation, " Journal of Neurochemistry, vol. 88, no. 2, pp. 494-501, 2004. (Pubitemid 38084565)
39. A. Kreisler, P. Gele, J.-F. Wiart, M. Lhermitte, A. Destee, and R. Bordet, "Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not, " Brain Research, vol. 1135, no. 1, pp. 77-84, 2007. (Pubitemid 46176827)
40. D. Deplanque, P. Gele, O. Petrault, et al., "Peroxisome proliferator-activated receptor-α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment, " Journal of Neuroscience, vol. 23, no. 15, pp. 6264-6271, 2003. (Pubitemid 36875628)
41. H. Inoue, X.-F. Jiang, T. Katayama, S. Osada, K. Umesono, and S. Namura, "Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferatoractivated receptor α in mice, " Neuroscience Letters, vol. 352, no. 3, pp. 203-206, 2003. (Pubitemid 38367603)
42. T. Ouk, O. Petrault, S. Gautier, et al., "Acute treatment by a PPAR-α agonist decreases cerebral infarct volume and prevents post-ischemic endothelium and Kir 2.1 impairment, " Journal of Cerebral Blood Flow andMetabolism, vol. 25, p. S56, 2005.
43. M. Collino, M. Aragno, R. Mastrocola, et al., "Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-α agonist WY14643, " Free Radical Biology and Medicine, vol. 41, no. 4, pp. 579-589, 2006. (Pubitemid 44080506)
44. T. Shimazu, I. Inoue, N. Araki, et al., "A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia, " Stroke, vol. 36, no. 2, pp. 353-359, 2005. (Pubitemid 40170822)
45. S. Sundararajan, J. L. Gamboa, N. A. Victor, E. W. Wanderi, W. D. Lust, and G. E. Landreth, "Peroxisome proliferatoractivated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia, " Neuroscience, vol. 130, no. 3, pp. 685-696, 2005. (Pubitemid 39601441)
46. A. Iwashita, Y. Muramatsu, T. Yamazaki, et al., "Neuroprotective efficacy of the peroxisome proliferator-activated receptor δ-selective agonists in vitro and in vivo, " Journal of Pharmacology and Experimental Therapeutics, vol. 320, no. 3, pp. 1087-1096, 2007. (Pubitemid 46294065)
47. A. E. Lovett-Racke, R. Z. Hussain, S. Northrop, et al., "Peroxisome proliferator-activated receptor α agonists as therapy for autoimmune disease, " Journal of Immunology, vol. 172, no. 9, pp. 5790-5798, 2004. (Pubitemid 38542085)
48. S. Dasgupta, A. Roy, M. Jana, D. M. Hartley, and K. Pahan, "Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-α, " Molecular Pharmacology, vol. 72, no. 4, pp. 934-946, 2007. (Pubitemid 47481416)
49. P. E. Polak, S. Kalinin, R. C. Dello, et al., "Protective effects of a peroxisome proliferator-activated receptor-β/δ agonist in experimental autoimmune encephalomyelitis, " Journal of Neuroimmunology, vol. 168, no. 1-2, pp. 65-75, 2005. (Pubitemid 41396404)
50. M. Niino, K. Iwabuchi, S. Kikuchi, et al., "Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ, " Journal of Neuroimmunology, vol. 116, no. 1, pp. 40-48, 2001. (Pubitemid 32322638)
51. C. Natarajan and J. J. Bright, "Peroxisome proliferatoractivated receptor-gamma agonist inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation, " Genes and Immunity, vol. 3, no. 2, pp. 59-70, 2002. (Pubitemid 38961111)
52. D. L. Feinstein, E. Galea, V. Gavrilyuk, et al., "Peroxisome proliferator-activated receptor-γ agonists prevent experimental autoimmune encephalomyelitis, " Annals of Neurology, vol. 51, no. 6, pp. 694-702, 2002. (Pubitemid 34568847)
53. M. Jana, A. Jana, X. Liu, S. Ghosh, and K. Pahan, "Involvement of phosphatidylinositol 3-kinase-mediated upregulation of IκBα in anti-inflammatory effect of gemfibrozil in microglia, " Journal of Immunology, vol. 179, no. 6, pp. 4142-4152, 2007.
54. P. D. Drew, J. Xu, P. D. Storer, J. A. Chavis, and M. K. Racke, "Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders, " Neurochemistry International, vol. 49, no. 2, pp. 183-189, 2006. (Pubitemid 43867076)
55. J. Xu, P. D. Storer, J. A. Chavis, M. K. Racke, and P. D. Drew, "Agonists for the peroxisome proliferator-activated receptor-α and the retinoid X receptor inhibit inflammatory responses of microglia, " Journal of Neuroscience Research, vol. 81, no. 3, pp. 403-411, 2005. (Pubitemid 41359295)
56. K. Pahan, M. Jana, X. Liu, B. S. Taylor, C. Wood, and S. M. Fischer, "Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes, " Journal of Biological Chemistry, vol. 277, no. 48, pp. 45984-45991, 2002. (Pubitemid 35417583)
57. S. Schmidt, E. Moric, M. Schmidt, M. Sastre, D. L. Feinstein, and M. T. Heneka, "Anti-inflammatory and antiproliferative actions of PPAR-γ agonists on T lymphocytes derived from MS patients, " Journal of Leukocyte Biology, vol. 75, no. 3, pp. 478-485, 2004. (Pubitemid 38316379)
58. C. N. Coleman, H. B. Stone, J. E. Moulder, and T. C. Pellmar, "Modulation of radiation injury, " Science, vol. 304, no. 5671, pp. 693-694, 2004. (Pubitemid 38560865)
59. H. B. Stone, W. H. McBride, and C. N. Coleman, "Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland September 6-8, 2000, " Radiation Research, vol. 157, no. 2, pp. 204-223, 2002. (Pubitemid 34101373)
60. A. Jemal, R. Siegel, E. Ward, et al., "Cancer statistics, 2008, " CA: A Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71-96, 2008. (Pubitemid 351521864)
61. J. Li, S. M. Bentzen, J. Li, M. Renschler, and M. P. Mehta, "Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis, " International Journal of Radiation Oncology, Biology, Physics, vol. 71, no. 1, pp. 64-70, 2008. (Pubitemid 351506468)
62. P. D. Brown, A. L. Asher, and E. Farace, "Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed, " International Journal of Radiation Oncology, Biology, Physics, vol. 70, no. 5, pp. 1305-1309, 2008.
63. D. Khuntia, P. Brown, J. Li, and M. P. Mehta, "Whole-brain radiotherapy in the management of brainmetastasis, " Journal of Clinical Oncology, vol. 24, no. 8, pp. 1295-1304, 2006.
64. E. G. Shaw and M. E. Robbins, "The management of radiation-induced brain injury, " Cancer Treatment and Research, vol. 128, pp. 7-22, 2006.
65. P. J. Tofilon and J. R. Fike, "The radioresponse of the central nervous system: a dynamic process, " Radiation Research, vol. 153, no. 4, pp. 357-370, 2000. (Pubitemid 30185388)
66. R. W. Butler and J. K. Haser, "Neurocognitive effects of treatment for childhood cancer, " Mental Retardation and Developmental Disabilities Research Reviews, vol. 12, no. 3, pp. 184-191, 2006. (Pubitemid 44646327)
67. T. E. Schultheiss, L. C. Stephens, and M. H. Maor, "Analysis of the histopathology of radiation myelopathy, " International Journal of Radiation Oncology, Biology, Physics, vol. 14, no. 1, pp. 27-32, 1988. (Pubitemid 18059125)
68. J. R. Crossen, D. Garwood, E. Glatstein, and E. A. Neuwelt, "Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy, " Journal of Clinical Oncology, vol. 12, no. 3, pp. 627-642, 1994. (Pubitemid 24079908)
69. S. M. Bentzen, "Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology, " Nature Reviews Cancer, vol. 6, no. 9, pp. 702-713, 2006. (Pubitemid 44286002)
70. L. M. DeAngelis, J.-Y. Delattre, and J. B. Posner, "Radiationinduced dementia in patients cured of brain metastases, " Neurology, vol. 39, no. 6, pp. 789-796, 1989. (Pubitemid 19150153)
71. T. B. Johannesen, H. H. Lien, K. H. Hole, and K. Lote, "Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy, " Radiotherapy and Oncology, vol. 69, no. 2, pp. 169-176, 2003. (Pubitemid 37485876)
72. D. D. Roman and P. W. Sperduto, "Neuropsychological effects of cranial radiation: current knowledge and future directions, " International Journal of Radiation Oncology, Biology, Physics, vol. 31, no. 4, pp. 983-998, 1995.
73. M. L. Monje and T. Palmer, "Radiation injury and neurogenesis, " Current Opinion in Neurology, vol. 16, no. 2, pp. 129-134, 2003. (Pubitemid 36521196)
74. Y. Yoneoka, M. Satoh, K. Akiyama, K. Sano, Y. Fujii, and R. Tanaka, "An experimental study of radiation-induced cognitive dysfunction in an adult rat model, " British Journal of Radiology, vol. 72, no. 864, pp. 1196-1201, 1999. (Pubitemid 30028933)
75. E. J. Dropcho, "Central nervous system injury by therapeutic irradiation, " Neurologic Clinics, vol. 9, no. 4, pp. 969-988, 1991.
76. J. Brush, S. L. Lipnick, T. Phillips, J. Sitko, J. T. McDonald, and W. H. McBride, "Molecular mechanisms of late normal tissue injury, " Seminars in Radiation Oncology, vol. 17, no. 2, pp. 121-130, 2007. (Pubitemid 46467382)
77. R. S. Jaenke, M. E. Robbins, T. Bywaters, E. Whitehouse, M. Rezvani, and J. W. Hopewell, "Capillary endothelium: target site of renal radiation injury, " Laboratory Investigation, vol. 68, no. 4, pp. 396-405, 1993. (Pubitemid 23136159)
78. P. Rubin, J. Finkelstein, and D. Shapiro, "Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast, " International Journal of Radiation Oncology, Biology, Physics, vol. 24, no. 1, pp. 93-101, 1992.
79. J. W. Denham and M. Hauer-Jensen, "The radiotherapeutic injury-a complex 'wound', " Radiotherapy and Oncology, vol. 63, no. 2, pp. 129-145, 2002.
80. S. Mizumatsu, M. L. Monje, D. R. Morhardt, R. Rola, T. D. Palmer, and J. R. Fike, "Extreme sensitivity of adult neurogenesis to low doses of X-irradiation, " Cancer Research, vol. 63, no. 14, pp. 4021-4027, 2003. (Pubitemid 36917922)
81. M. L. Monje, H. Toda, and T. D. Palmer, "Inflammatory blockade restores adult hippocampal neurogenesis, " Science, vol. 302, no. 5651, pp. 1760-1765, 2003. (Pubitemid 37505739)
82. M. Andres-Mach, R. Rola, and J. R. Fike, "Radiation effects on neural precursor cells in the dentate gyrus, " Cell and Tissue Research, vol. 331, no. 1, pp. 251-262, 2008. (Pubitemid 350265490)
83. C. L. Limoli, E. Giedzinski, J. Baure, R. Rola, and J. R. Fike, "Altered growth and radiosensitivity in neural precursor cells subjected to oxidative stress, " International Journal of Radiation Biology, vol. 82, no. 9, pp. 640-647, 2006. (Pubitemid 44581947)
84. H. Fukuda, A. Fukuda, C. Zhu, et al., "Irradiation-induced progenitor cell death in the developing brain is resistant to erythropoietin treatment and caspase inhibition, " Cell Death and Differentiation, vol. 11, no. 11, pp. 1166-1178, 2004. (Pubitemid 39529959)
85. K. Manda, M. Ueno, and K. Anzai, "Cranial irradiationinduced inhibition of neurogenesis in hippocampal dentate gyrus of adult mice: attenuation by melatonin pretreatment, " Journal of Pineal Research, vol. 46, no. 1, pp. 71-78, 2009.
86. M. L. Block, L. Zecca, and J.-S. Hong, "Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, " Nature Reviews Neuroscience, vol. 8, no. 1, pp. 57-69, 2007. (Pubitemid 46011999)
87. H.-M. Gao and J.-S. Hong, "Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression, " Trends in Immunology, vol. 29, no. 8, pp. 357-365, 2008.
88. J.-H. Hong, C.-S. Chiang, I. L. Campbell, J.-R. Sun, H. R. Withers, and W. H. McBride, "Induction of acute phase gene expression by brain irradiation, " International Journal of Radiation Oncology, Biology, Physics, vol. 33, no. 3, pp. 619-626, 1995.
89. U. Raju, G. J. Gumin, and P. J. Tofilon, "NFκB activity and target gene expression in the rat brain after one and two exposures to ionizing radiation, " Radiation Oncology Investigations, vol. 7, no. 3, pp. 145-152, 1999. (Pubitemid 29310096)
90. U. Raju, G. J. Gumin, and P. J. Tofilon, "Radiation-induced transcription factor activation in the rat cerebral cortex, " International Journal of Radiation Biology, vol. 76, no. 8, pp. 1045-1053, 2000. (Pubitemid 30488613)
91. C.-S. Chiang, J.-H. Hong, A. Stalder, J.-R. Sun, H. R. Withers, and W. H. McBride, "Delayed molecular responses to brain irradiation, " International Journal of Radiation Biology, vol. 72, no. 1, pp. 45-53, 1997. (Pubitemid 27316089)
92. M. L. Monje, H. Vogel, M. Masek, K. L. Ligon, P. G. Fisher, and T. D. Palmer, "Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies, " Annals of Neurology, vol. 62, no. 5, pp. 515-520, 2007. (Pubitemid 350308776)
93. D. T. Balu and I. Lucki, "Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology, " Neuroscience and Biobehavioral Reviews, vol. 33, no. 3, pp. 232-252, 2009.
94. M. D. Saxe, F. Battaglia, J.-W. Wang, et al., "Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17501-17506, 2006. (Pubitemid 44788998)
95. O. K. Abayomi, "Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors, " Acta Oncologica, vol. 41, no. 4, pp. 346-351, 2002.
96. M. L. Monje, S. Mizumatsu, J. R. Fike, and T. D. Palmer, "Irradiation induces neural precursor-cell dysfunction, " Nature Medicine, vol. 8, no. 9, pp. 955-962, 2002. (Pubitemid 35033699)
97. J. Raber, R. Rola, A. LeFevour, et al., "Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis, " Radiation Research, vol. 162, no. 1, pp. 39-47, 2004. (Pubitemid 39044717)
98. R. Rola, J. Raber, A. Rizk, et al., "Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice, " Experimental Neurology, vol. 188, no. 2, pp. 316-330, 2004. (Pubitemid 38891593)
99. Y. Fan, Z. Liu, P. R. Weinstein, J. R. Fike, and J. Liu, "Environmental enrichment enhances neurogenesis and improves functional outcome after cranial irradiation, " European Journal of Neuroscience, vol. 25, no. 1, pp. 38-46, 2007. (Pubitemid 46096221)
100. C. T. Ekdahl, J.-H. Claasen, S. Bonde, Z. Kokaia, and O. Lindvall, "Inflammation is detrimental for neurogenesis in adult brain, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 23, pp. 13632-13637, 2003. (Pubitemid 37444791)
101. S. M. de la Monte and J. R. Wands, "Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease, " Journal of Alzheimer'sDisease, vol. 9, no. 2, pp. 167-181, 2006. (Pubitemid 44088244)
102. W. Zhao, S. Iskandar, M. Kooshki, J. G. Sharpe, V. Payne, and M. E. Robbins, "Knocking out peroxisome proliferatoractivated receptor (PPAR) α inhibits radiation-induced apoptosis in the mouse kidney through activation of NF-κB and increased expression of IAPs, " Radiation Research, vol. 167, no. 5, pp. 581-591, 2007. (Pubitemid 351292965)
103. C. Linard, O. Grémy, and M. Benderitter, "Reduction of peroxisome proliferation-activated receptor γ expression by γ-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist, " Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 3, pp. 911-920, 2008. (Pubitemid 351397844)
104. S. Kyrkanides, J. A. Olschowka, J. P. Williams, J. T. Hansen, and M. K. O'Banion, "TNFα and IL-1β mediate intercellular adhesion molecule-1 induction viamicroglia-astrocyte interaction in CNS radiation injury, " Journal ofNeuroimmunology, vol. 95, no. 1-2, pp. 95-106, 1999. (Pubitemid 29173026)
105. S. Kyrkanides, A. H. Moore, J. A. Olschowka, et al., " Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury, " Molecular Brain Research, vol. 104, no. 2, pp. 159-169, 2002.
106. S.-Y. Hwang, J.-S. Jung, T.-H. Kim, et al., "Ionizing radiation induces astrocyte gliosis through microglia activation, " Neurobiology of Disease, vol. 21, no. 3, pp. 457-467, 2006. (Pubitemid 43277528)
107. S. Ramanan, M. Kooshki, W. Zhao, F.-C. Hsu, andM. E. Robbins, "PPARα ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-κB and AP-1 pathways, " Free Radical Biology & Medicine, vol. 45, no. 12, pp. 1695-1704, 2008.
108. V. Waetzig, K. Czeloth, U. Hidding, et al., "c-Jun Nterminal kinases (JNKs) mediate pro-inflammatory actions of microglia, " Glia, vol. 50, no. 3, pp. 235-246, 2005. (Pubitemid 40769853)
109. L. Liu, Y. Li, L. J. Van Eldik, W. S. T. Griffin, and S. W. Barger, "S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors, " Journal of Neurochemistry, vol. 92, no. 3, pp. 546-553, 2005. (Pubitemid 40189458)
110. Y. J. Jeon, S. H. Han, Y.W. Lee, M. Lee, K. H. Yang, and H.M. Kim, "Dexamethasone inhibits IL-1β gene expression in LPSstimulated RAW 264.7 cells by blocking NF-κB/Rel and AP-1 activation, " Immunopharmacology, vol. 48, no. 2, pp. 173-183, 2000. (Pubitemid 30608674)
111. W.-G. Deng, A. J. Montero, and K. K. Wu, "Interferon-γ suppresses cyclooxygenase-2 promoter activity by inhibiting C-Jun and C/EBPβ binding, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 8, pp. 1752-1759, 2007. (Pubitemid 47207170)
112. J. L. Swantek, M. H. Cobb, and T. D. Geppert, "Jun Nterminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK, " Molecular and Cellular Biology, vol. 17, no. 11, pp. 6274-6282, 1997. (Pubitemid 27451171)
113. P. Delerive, K. De Bosscher, S. Besnard, et al., "Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative crosstalk with transcription factors NF-κB and AP-1, " Journal of Biological Chemistry, vol. 274, no. 45, pp. 32048-32054, 1999.
114. J. Kim, J.-H. Ahn, J.-H. Kim, et al., "Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway, " Experimental Eye Research, vol. 84, no. 5, pp. 886-893, 2007. (Pubitemid 46590130)
115. M. Yamashita, "Peroxisome proliferator-activated receptor α-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells, " European Journal of Pharmacology, vol. 556, no. 1-3, pp. 172-180, 2007. (Pubitemid 46073991)
116. P. R. Devchand, H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli, "The PPARα-leukotriene B4 pathway to inflammation control, " Nature, vol. 384, no. 6604, pp. 39-43, 1996.
117. P. Delerive, P. Gervois, J.-C. Fruchart, and B. Staels, "Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferatoractivated receptor-α activators, " Journal of Biological Chemistry, vol. 275, no. 47, pp. 36703-36707, 2000. (Pubitemid 32002075)
118. M. E. Poynter and R. A. Daynes, "Peroxisome proliferatoractivated receptor α activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging, " Journal of Biological Chemistry, vol. 273, no. 49, pp. 32833-32841, 1998. (Pubitemid 28557672)
119. J. N. Crawley, J. K. Belknap, A. Collins, et al., "Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies, " Psychopharmacology, vol. 132, no. 2, pp. 107-124, 1997. (Pubitemid 27338986)
120. J. R. Collins-Underwood, W. Zhao, J. G. Sharpe, and M. E. Robbins, "NADPH oxidase mediates radiation-induced oxidative stress in rat brain microvascular endothelial cells, " Free Radical Biology & Medicine, vol. 45, no. 6, pp. 929-938, 2008.
121. T. Herdegen, F.-X. Claret, T. Kallunki, et al., "Lasting Nterminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury, " Journal of Neuroscience, vol. 18, no. 14, pp. 5124-5135, 1998. (Pubitemid 28311930)
122. A. Behrens, M. Sibilia, and E. F. Wagner, "Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation, " Nature Genetics, vol. 21, no. 3, pp. 326-329, 1999. (Pubitemid 29124945)
123. J. R. Bethea, M. Castro, R.W. Keane, T. T. Lee, W. D. Dietrich, and R. P. Yezierski, "Traumatic spinal cord injury induces nuclear factor-κB activation, " Journal of Neuroscience, vol. 18, no. 9, pp. 3251-3260, 1998. (Pubitemid 28186018)
124. W. S. T. Griffin, J. G. Sheng, M. C. Royston, et al., "Glialneuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression, " Brain Pathology, vol. 8, no. 1, pp. 65-72, 1998. (Pubitemid 28055765)
125. M. Mogi, M. Harada, H. Narabayashi, H. Inagaki, M. Minami, and T. Nagatsu, "Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease, " Neuroscience Letters, vol. 211, no. 1, pp. 13-16, 1996. (Pubitemid 26228016)
126. B. D. Trapp, J. Peterson, R.M. Ransohoff, R. Rudick, S. Mörk, and L. Bö, "Axonal transection in the lesions of multiple sclerosis, " The New England Journal of Medicine, vol. 338, no. 5, pp. 278-285, 1998. (Pubitemid 28065253)
127. E. L. Tobinick and H. Gross, "Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration, " Journal of Neuroinflammation, vol. 5, no. 2, 10 pages, 2008.
128. C. Song and D. Horrobin, "Omega-3 fatty acid ethyleicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1β administration, " Journal of Lipid Research, vol. 45, no. 6, pp. 1112-1121, 2004. (Pubitemid 38679507)
129. K. I. Andreasson, A. Savonenko, S. Vidensky, et al., "Agedependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice, " Journal of Neuroscience, vol. 21, no. 20, pp. 8198-8209, 2001. (Pubitemid 32952775)
130. P. Ye and A. J. D'Ercole, "Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-α-induced injury, " Endocrinology, vol. 140, no. 7, pp. 3063-3072, 1999. (Pubitemid 30650620)
131. J. L. Takahashi, F. Giuliani, C. Power, Y. Imai, and V.W. Yong, "Interleukin-1β promotes oligodendrocyte death through glutamate excitotoxicity, " Annals of Neurology, vol. 53, no. 5, pp. 588-595, 2003. (Pubitemid 36529432)
132. W. S. Sheng, S. Hu, H. T. Ni, T. N. Rowen, J. R. Lokensgard, and P. K. Peterson, "TNF-α-induced chemokine production and apoptosis in human neural precursor cells, " Journal of Leukocyte Biology, vol. 78, no. 6, pp. 1233-1241, 2005. (Pubitemid 41779229)
133. G. D. Girnun, F. E. Domann, S. A. Moore, and M. E. Robbins, "Identification of a functional peroxisome proliferatoractivated receptor response element in the rat catalase promoter, " Molecular Endocrinology, vol. 16, no. 12, pp. 2793-2801, 2002. (Pubitemid 36020658)
134. J. Hwang, D. J. Kleinhenz, B. Lassegue, K. K. Griendling, S. Dikalov, and C. M. Hart, "Peroxisome proliferatoractivated receptor-γ ligands regulate endothelial membrane superoxide production, " American Journal of Physiology, vol. 288, no. 4, pp. C899-C905, 2005. (Pubitemid 40395068)
135. I. Inoue, S.-I. Goto, T. Matsunaga, et al., "The ligands/ activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells, " Metabolism, vol. 50, no. 1, pp. 3-11, 2001. (Pubitemid 32058541)
136. Y. Fan, Y. Wang, Z. Tang, et al., "Suppression of proinflammatory adhesion molecules by PPAR-δ in human vascular endothelial cells, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 315-321, 2008. (Pubitemid 351161205)
137. R. S. Rosenson, "Fenofibrate: treatment of hyperlipidemia and beyond, " Expert Review of Cardiovascular Therapy, vol. 6, no. 10, pp. 1319-1330, 2008.
138. H.-C. Hsu, Y.-T. Lee, H.-T. Yeh, and M.-F. Chen, "Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia, " Journal of Laboratory and Clinical Medicine, vol. 137, no. 6, pp. 414-421, 2001. (Pubitemid 32473620)
139. G. E. O. Muscat and U. Dressel, "Cardiovascular disease and PPARδ: targeting the risk factors, " Current Opinion in Investigational Drugs, vol. 6, no. 9, pp. 887-894, 2005. (Pubitemid 41269368)